Impact of COVID-19 morbimortality of oncological patients in Teresina-PI

Authors

DOI:

https://doi.org/10.33448/rsd-v11i2.25486

Keywords:

Impact; Cancer; COVID-19.

Abstract

The high mortality rate of covid-19 6.7% worldwide, (Turaga & Girotra, 2020), associated with a high transmissibility rate, requires a more targeted study for a portion of the population, which is within the comorbidities, which are cancer patients. Objectives: To verify changes in the hospitalization rates of cancer patients, and the influence of COVID-19 on the death of cancer patients. Methodology: Retrospective study that consists of analyzing the hospitalization and mortality rate of cancer patients between April 2019 and April 2021, through analysis of data available in open databases such as Opendatasus, datasus and the website of the health department of the state of Piauí. The present study has a cross-sectional statistical analysis, which obtained a P<0.0001 through the application of the binomial test, representing a relevance of 99.99%, which included patients with a previous diagnosis of cancer, cancer patients concomitantly diagnosed with COVID -19 through RT-PC; of any sex, age, with a previous diagnosis of cancer who were hospitalized or died, within a period of 2 years (2019-2020 and 2020-2021) in Teresina-PI. Results: A significant decline in hospitalization and mortality of cancer patients was observed over the period 2020-2021.

References

Emanuel, E. J., Persad, G., Upshur, R., Thome, B., Parker, M., Glickman, A., Zhang, C., Boyle, C., Smith, M., & Phillips, J. P. (2020). Fair Allocation of Scarce Medical Resources in the Time of Covid-19. New England Journal of Medicine, 382(21). https://doi.org/10.1056/nejmsb2005114

Turaga, K. K., & Girotra, S. (2020). Are We Harming Cancer Patients by Delaying Their Cancer Surgery During the COVID-19 Pandemic? Annals of Surgery, Publish Ahead of Print. https://doi.org/10.1097/sla.0000000000003967

Abikoye, T. M. (2020). Collateral damage: the impact of the COVID-19 pandemic on the care of a patient with tuberculous neuroretinitis in Lagos, Nigeria. Pan African Medical Journal, 35. https://doi.org/10.11604/pamj.supp.2020.35.2.24691

Dantas Ferreira, J., Da Silva de Lima, F. C., Pinto Oliveira, J. F., De Camargo Cancela, M., & De Oliveira Santos, M. (2020). Covid-19 e Câncer: Atualização de Aspectos Epidemiológicos. Revista Brasileira de Cancerologia, 66(TemaAtual). https://doi.org/10.32635/2176-9745.rbc.2020v66ntemaatual.1013

Oncology, T. L. (2020). COVID-19: global consequences for oncology. The Lancet Oncology, 21(4), 467. https://doi.org/10.1016/S1470-2045(20)30175-3

Passos, H., Alves, M., Baumworcel, L., Paulo, J., Vieira, C., Dantas, J., Garcez, S., Carlos, A., Sousa, S., São, H., & Rede D'or, L. (n.d.). Relato de Caso Palavras-chave. https://doi.org/10.36660/abc.20200427

Al-Shamsi, H. O., Alhazzani, W., Alhuraiji, A., Coomes, E. A., Chemaly, R. F., Almuhanna, M., Wolff, R., Nuhad, I. K., Chua, M. L. K., Hotte, S. J., Meyers, B. M., Elfiki, T., Curigliano, G., Eng, C., Grothey, A., & Xie, C. (2020). A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. The Oncologist. https://doi.org/10.1634/theoncologist.2020-0213

Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., Zhang, Z., You, H., Wu, M., Zheng, Q., Xiong, Y., Xiong, H., Wang, C., Chen, C., Xiong, F., Zhang, Y., Peng, Y., Ge, S., Zhen, B., & Yu, T. (2020). Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak. Cancer Discovery, CD–4200422. https://doi.org/10.1158/2159-8290.cd-20-0422

Raymond, E., Thieblemont, C., Alran, S., & Faivre, S. (2020). Impact of the COVID-19 Outbreak on the Management of Patients with Cancer. Targeted Oncology, 15(3), 249–259. https://doi.org/10.1007/s11523-020-00721-1

Jindal, V., Sahu, K. K., Gaikazian, S., Siddiqui, A. D., & Jaiyesimi, I. (2020). Cancer treatment during COVID-19 pandemic. Medical Oncology, 37(7). https://doi.org/10.1007/s12032-020-01382-w

Robilotti, E. V., Babady, N. E., Mead, P. A., Rolling, T., Perez-Johnston, R., Bernardes, M., Bogler, Y., Caldararo, M., Ortiz, C. J. F., Glickman, M. S., Joanow, A., Kaltsas, A., Lee, Y. J., Bianchi, A. L., Mariano, A., Morjaria, S., Nawar, T., Papanicolaou, G. A., Predmore, J., & Redelman-Sidi, G. (2020). Determinants of Severity in Cancer Patients with COVID-19 Illness. Nature Medicine, 26(8), 1218–1223. https://doi.org/10.1038/s41591-020-0979-0

Lee, L. Y., Cazier, J.-B., Angelis, V., Arnold, R., Bisht, V., Campton, N. A., Chackathayil, J., Cheng, V. W., Curley, H. M., Fittall, M. W., Freeman-Mills, L., Gennatas, S., Goel, A., Hartley, S., Hughes, D. J., Kerr, D., Lee, A. J., Lee, R. J., McGrath, S. E., & Middleton, C. P. (2020). COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. The Lancet, 395(10241), 1919–1926. https://doi.org/10.1016/S0140-6736(20)31173-9

Jee, J., Foote, M. B., Lumish, M., Stonestrom, A. J., Wills, B., Narendra, V., Avutu, V., Murciano-Goroff, Y. R., Chan, J. E., Derkach, A., Philip, J., Belenkaya, R., Kerpelev, M., Maloy, M., Watson, A., Fong, C., Janjigian, Y., Diaz, L. A., Bolton, K. L., & Pessin, M. S. (2020). Chemotherapy and COVID-19 Outcomes in Patients With Cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 38(30), 3538–3546. https://doi.org/10.1200/JCO.20.01307

Alcântara, R. C., Silva Junior, L. C. F., Arnozo, G. M., Oliveira, T. F. de, Santana, F. M. S., Silva Filho, E. R. da, Santos, A. G. G. dos, Cunha, E. J. O. da, Aquino, S. H. S. de, Mesquita, R. da R., & Souza, C. D. F. de. (2020). Covid-19 em Pacientes Oncológicos: uma Revisão do Perfil Clínico-Epidemiológico. Revista Brasileira de Cancerologia, 66(TemaAtual). https://doi.org/10.32635/2176-9745.rbc.2020v66ntemaatual.1046

Carcamo, M., Stumpf, E. R. T., & Mariot, M. P. (2020). Avaliação de servidores em Educação sobre condições de risco para a COVID-19. Revista Thema, 18, 111–123. https://doi.org/10.15536/thema.v18.especial.2020.111-123.1825

Siddiqi, H. K., & Mehra, M. R. (2020). COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging Proposal. The Journal of Heart and Lung Transplantation, 39(5). https://doi.org/10.1016/j.healun.2020.03.012

Saini, K. S., de las Heras, B., de Castro, J., Venkitaraman, R., Poelman, M., Srinivasan, G., Saini, M. L., Verma, S., Leone, M., Aftimos, P., & Curigliano, G. (2020). Effect of the COVID-19 pandemic on cancer treatment and research. The Lancet Haematology. https://doi.org/10.1016/s2352-3026(20)30123-x

Araujo SE, Leal A, Centrone AF, Teich VD, Malheiro DT, Cypriano AS, et al. Impacto da COVID-19 sobre o atendimento de pacientes oncológicos: experiência de um centro oncológico localizado em um epicentro Latino-Americano da pandemia. einstein (São Paulo). 2021;19:eAO6282. https://doi.org/10.31744/einstein_journal/2021AO6282

Blay, J. Y., Boucher, S., Le Vu, B., Cropet, C., Chabaud, S., Perol, D., Barranger, E., Campone, M., Conroy, T., Coutant, C., De Crevoisier, R., Debreuve-Theresette, A., Delord, J. P., Fumoleau, P., Gentil, J., Gomez, F., Guerin, O., Jaffré, A., Lartigau, E., & Lemoine, C. (2021). Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France. ESMO Open, 6(3), 100134. https://doi.org/10.1016/j.esmoop.2021.100134

Degeling, K., Baxter, N. N., Emery, J., Jenkins, M. A., Franchini, F., Gibbs, P., Mann, G. B., McArthur, G., Solomon, B. J., & IJzerman, M. J. (2021). An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic. Asia-Pacific Journal of Clinical Oncology, 17(4), 359–367. https://doi.org/10.1111/ajco.13505

Gupta, N., Chauhan, A. S., Prinja, S., & Pandey, A. K. (2021). Impact of COVID-19 on Outcomes for Patients With Cervical Cancer in India. JCO Global Oncology, 7, 716–725. https://doi.org/10.1200/go.20.00654

Downloads

Published

31/01/2022

How to Cite

SIQUEIRA, L. N. R. .; CARVALHO FILHO, L. A. de .; RIBEIRO, J. L. V. . Impact of COVID-19 morbimortality of oncological patients in Teresina-PI. Research, Society and Development, [S. l.], v. 11, n. 2, p. e15411225486, 2022. DOI: 10.33448/rsd-v11i2.25486. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/25486. Acesso em: 18 apr. 2024.

Issue

Vol. 11 No. 2

Section

Health Sciences

License

Copyright (c) 2022 Laís Neiva Rego Siqueira; Luiz Antonio de Carvalho Filho; João Luiz Vieira Ribeiro

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.